Thank you for the additional information on "free trade" with China.
While acknowledging "challenges" in dealing with China, Mankiw's testimony obviously was intended to support the current course. Access to the full committee hearing gives everyone a chance to evaluate all sides of the question. Other hearings were held on the 14th, but I have not found the link . . . yet. C-Span televised it.
An excerpt from a small medical manufacturer's submission for the record:
Carus Chemical Company (“Carus”) of Peru, Illinois is a small family-owned company founded in 1915. Carus has 205 U.S. employees. Carus is the only remaining U.S. producer of potassium permanganate, a chemical that has important applications, including drinking water and wastewater treatment, and contaminated site clean-up.
[. . .]
Carus and its employees have very serious concerns about the unwillingness of Chinese enterprises to abide by existing international trade rules, particularly rules against the dumping of products. Our experience in recent years has repeatedly demonstrated that some Chinese enterprises simply do not take these rules seriously and will do whatever they can -- including making up data, forging documents and seriously misleading U.S. authorities -- in an effort to evade the antidumping laws. We also have broader policy concerns about the inability of existing U.S. trade laws and trade policies to prevent the continuing erosion of our U.S. manufacturing base. In particular, we are dismayed at continued reports that modern, efficient and environmentally sensitive facilities that provide good jobs to U.S. workers are being forced to give way to inefficient and environmentally damaging Chinese plants operated by enterprises that have little regard for their workers or for rules of fair trade.